Data-Gouv-ML/pcri-informations-sur-les-projets-laureats huggingface dataset:
Optimizing access to long-term care? Impact of long-term care policies on use, health and equity among the elderly (LTCpolicies)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Standard European Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Economic Sciences
Countries involved: Netherlands
Call: Individual Fellowships (H2020-MSCA-IF-2018, 2018)
Start date: 2020-09-01
End date: 2022-08-31
Duration (months): 24.0
Total project cost (EUR): 187572.48
EU funding (EUR): 187572.48
Participants: 1
Project status: CLOSED

OECD countries face the aging of their population, a demographic trend that will amplify in the next decades. This causes a substantial increase in the number of the disabled elderly, who require assistance with activities of daily living. Reconciling the societal concern for ensuring appropriate long-term care (LTC) to the disabled elderly and the pressure on public spending is a major challenge that all OECD countries struggle with. Governments aim at containing rising LTC costs by setting eligibility criteria and cost-sharing rules; such measures may however impact the efficiency and equity of LTC policies. How does the design of LTC policies affect LTC use at both the individual level and across population groups? And what are the downstream effects LTC use may have on health and health care use? This proposal aims at providing robust empirical evidence on these questions by making use of conceptual and measurement tools from applied economics. Identification of causal relationships will be achieved by exploiting quasi-experimental variation in LTC use and innovative individual-level data, which combine survey and administrative sources. My research will yield three main contributions to the economic literature and to our understanding of LTC policies. First, I will provide unprecedented insight on the impact of co-payments on nursing home entry in a European country, namely the Netherlands. Second, I will assess whether the under-use of LTC may deteriorate health and increase health care services. Finally, I will provide a comprehensive assessment of socio-economic inequalities in the use of LTC and its financing in France. This proposal tackles research questions that the international literature has left pending, in the context of two countries whose ongoing policy debates on LTC embody the trade-off faced by all European governments. It thus aims at contributing to evidence-based decisions in the field of LTC.

Keywords: long term care policies,population ageing,health care use,health inequalities,equity,efficiency,financial incentives
The European medical isotope programme: Production of high purity isotopes by mass separation (PRISMAP)

Framework: Horizon 2020 — Excellent Science
Programme: Research Infrastructures
Theme: Research infrastructures
Destination: Integrating activities and infrastructures
Action type: Research and Innovation actions
Countries involved: Austria,Germany,Germany,Italy,Austria,Norway,Belgium,Switzerland,Sweden,Switzerland,Belgium,Poland,Switzerland,Latvia,France,France,France,France,Denmark,United Kingdom,Portugal
Call: Integrating Activities for Starting Communities (H2020-INFRAIA-2020-1, 2020)
Start date: 2021-05-01
End date: 2025-04-30
Duration (months): 48.0
Total project cost (EUR): 5529507.5
EU funding (EUR): 4995257.5
Participants: 23
Project status: SIGNED

PRISMAP - The European medical isotope programme: Production of high purity isotopes by mass separation proposes to federate a consortium of the key European intense neutron sources, isotope mass separation facilities and high-power accelerators and cyclotrons, with leading biomedical research institutes and hospitals active in the translation of the emerging radionuclides into medical diagnosis and treatment. PRISMAP will create a single-entry point for a fragmented user community distributed amongst universities, research centres, industry and hospitals, in a similar way as the National Isotope Development Center NIDC supported by the Department of Energy (DOE) has provided radionuclide sources for users in the USA. PRISMAP brings together a consortium of 23 beneficiaries from 13 countries, one European Research Laboratory and an International Organisation. It further receives support of leading associations and institutions in the field such as the European Association of Nuclear Medicine (EANM) and the International Atomic Energy Agency (IAEA). Our main goal is to provide a sustainable source of high purity grade new radionuclides for medicine, involving from the onset upcoming major European infrastructures, to provide a single-entry point for all researchers active in this field including SMEs, global pharma, nuclear centres, hospitals and universities, using standardised access procedures. The new isotope enrichment and standardisation techniques triggered in PRISMAP will expand our services and provide them to yet unreachable remote European laboratories. PRISMAP thus strives to create a paradigm shift in the early phase research on radiopharmaceuticals, targeted drugs for cancer – one of the major diseases in Europe - theranostics and personalised medicine, shaping the European isotope landmark as a gold standard to accelerate the development of the pharma industry and ultimately of a better healthcare for the improvement of our citizens’ life.

Keywords: isotope mass separation,targeted molecular radiotherapy,targeted alpha therapy,theranostics,radionuclides,pet imaging,radiopharmaceuticals,nuclear medicine,precision medicine,cancer treatment
Familiarity is Key! Conceptualizing and Behaviourally Measuring Familiarity In-Situ (FamConMe)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Global Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Information Science and Engineering
Countries involved: Austria,United States
Call: Individual Fellowships (H2020-MSCA-IF-2020, 2020)
Start date: 2022-03-01
End date: 2024-08-31
Duration (months): 30.0
Total project cost (EUR): 226032.96
EU funding (EUR): 226032.96
Participants: 2
Project status: SIGNED

This interdisciplinary research project contributes to understanding and implementing familiarity in location-based systems through theoretical, methodological and applied advancements. The proposed research adds significantly to our knowledge of how to conceptualize familiarity with different environmental features (e.g., landmarks, routes, regions) and provides novel ways to assess it in-situ based on behavioural data. It provides important theoretical insights by disentangling and interrelating the different conceptualizations and measurements of familiarity. The project’s key methodological advancement is the unique combination of three different sensors to behaviourally assess familiarity during in-situ travel and spatial learning: Mobile eye tracking, high precision GNSS positioning, and head/body-worn Inertial Measurement Unit (e.g. providing acceleration data etc.) sensors are fused to study familiarity behaviourally in-situ. Machine learning and deep learning experiments on the behavioural data, singly and in combination, will be used to classify different levels of familiarity reflected in participants’ activities. The outcomes of this investigation form a basis for future research studies on how smart cities can adapt to its citizens' needs, based on their current state of spatial cognition – for which familiarity is a key example. These results contribute to the European Commission's policy “Smart Cities - Smart Living” and interplay with future programmes of the Horizon Europe cluster “Climate, Energy and Mobility” and the mission area “Climate-neutral and smart cities”.

Keywords: familiarity,behavioural measurement,classification,geographic information science,behavioural geography,spatial cognition,eye tracking,inertial measurement unit,trajectory
Resource and Cost Effective Conversion of Biomass to HydrocarbonTM Oil (Hydrofaction)

Framework: Horizon 2020 — Societal Challenges
Programme: Secure, clean and efficient energy
Action type: SME instrument
Countries involved: Denmark
Call: Stimulating the innovation potential of SMEs for a low carbon energy system (H2020-SMEINST-2-2014, 2014)
Start date: 2015-04-01
End date: 2017-03-31
Duration (months): 24.0
Total project cost (EUR): 2631165.75
EU funding (EUR): 1841816.0
Participants: 1
Project status: CLOSED

The ambition for the Project is to pave-the-way for commercialization and implementation of Steeper Energy Aps (SEA) innovative hydrothermal liquefaction technology platform: HydrofactionTM. The proprietary technology is a highly efficient method to produce renewable fuel oil with similarities to petroleum fuel oils. Timely commercialization will be achieved by bringing Hydrofaction to market via testing, scale-up and demonstration. Based on a proven new chemical process, using renewable low-cost (non-food) feedstocks, Hydrofaction Oil can be burned in CHP applications, used a substitute for low-sulphur marine diesel or may be upgraded to diesel or jet via traditional petroleum refineries. The Project will advance the design of the Hydrofaction technology platform and mature the Company’s preparedness to attract new investment while moving the TRL level from 6 to 8: a critical step toward the commercialization of Hydrofaction. The Project objectives include adjusting the product offering to meet the needs of technology users (licensees) and their customers (oil buyers) by lowering the risks associated with the performance of future commercial plants as well as improving or modifying the quality of Hydrofaction Oil. Within the design of the Project, Hydrofaction Oil will be produced from feedstocks provided by potential commercial partners as well as comprehensive testing of that oil at certified laboratories. Future licensees expect that the scaled demonstration plant, approximately 100 times larger than SEA’s current Pilot facility or 5.000 fuel tonne export capacity, will be representative in both physical design and operations to subsequent full-scale commercial plants to be based on 50.000 fuel tonne export modules transforming large amounts of biomass residuals to Hydrofaction Oil for oil refineries to upgrade to renewable diesel. Key milestones include advancing existing business partner/licensee/project relationships to signed LOIs and MOUs.

Keywords: thermochemical conversion,drop in biofuels,refinery bio feed,low sulphur marine diesel,jet fuel
Advanced Programming Environments for Exascale Data-Centric Computing (DataLocAbstractions)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Reintegration panel
Action type: Marie Skłodowska-Curie actions
Panel: Information Science and Engineering
Countries involved: Türkiye
Call: Marie Skłodowska-Curie Individual Fellowships (IF-EF) (H2020-MSCA-IF-2014, 2014)
Start date: 2015-04-01
End date: 2017-03-31
Duration (months): 24.0
Total project cost (EUR): 145845.6
EU funding (EUR): 145845.6
Participants: 1
Project status: CLOSED

Power efficiency has emerged as the primary design constraint for the next generation of computing systems and the dominant source of energy consumption has shifted from computing elements to the movement of data. This shift will make locality of data the new programming challenge of the decade. However, current programming environments take a compute-centric approach and do not reflect the realities of the architectural trends. For performance and energy efficiency reasons, there is a critical need for a new data-centric programming paradigm that takes data locality as a primary criterion. Moreover the next generation of high performance systems (Exascale Systems) will be equipped with 2048-core chips, requiring applications to expose over a thousand-way concurrency. For a smooth transition to these advanced technologies, this project proposes a theoretical foundation and programming abstractions; embodied in an API (Application Programming Interface) that provides a rich interface to address the dual challenges of data locality and increased on-chip parallelism for emerging parallel computing systems. The ultimate goal of the project is to integrate the proposed API into real-life applications that are of great interest to Europe. The project will study Turbulent Combustion as a motivating application class because of its importance in energy production. The proposed research, by reinventing the programming environment to better reflect the realities of future platforms, will facilitate the transition to Exascale of applications that are critical for strengthening European leadership in HPC.

Keywords: high performance computing,exascale computing,parallel programming models,parallel languages and libraries,compilers,computational fluid dynamics,turbulent combustion
Organic Ionic Plastic Crystals Nanocomposites for Safer Batteries (eJUMP)

Framework: Horizon 2020 — Excellent Science
Programme: Marie-Sklodowska-Curie Actions
Theme: Marie Skłodowska-Curie
Destination: Individual Fellowships (IF)-Global Fellowships
Action type: Marie Skłodowska-Curie actions
Panel: Chemistry
Countries involved: Spain,Australia
Call: Individual Fellowships (H2020-MSCA-IF-2017, 2017)
Start date: 2019-01-01
End date: 2021-12-31
Duration (months): 36.0
Total project cost (EUR): 245440.8
EU funding (EUR): 245440.8
Participants: 2
Project status: CLOSED

Nowadays, important safety concerns limit large-scale use of lithium batteries for electric vehicles and stationary storage. Despite their high ionic conductivity, conventional liquid electrolytes for lithium batteries are highly flammable and can leak out of the battery case. Safer electrolytes are needed to enable the next-generation of rechargeable batteries. The eJUMP Global Fellowship aims to develop innovative nanocomposites electrolytes based on Organic Ionic Plastic Cristals (OICPs) – a novel class of solid state electrolytes with intrinsic safety and high ionic conductivity. The eJUMP approach is to prepare composites materials from OIPCs and polymer nanoparticles – which can act both as reinforcement but also add function via a purposely designed nanoparticle interfaces. The knowledge generated by eJUMP will help to establish specific design criteria for the fabrication of this new class of solid electrolytes. The fellow – Dr. Luca Porcarelli – will carry out the research and training activities of the outgoing phase at the ARC Centre of Excellence in Electromaterials Science (Deakin University, Australia), under the supervision of Prof. Maria Forsyth. The incoming phase will take place at POLYMAT (University of the Basque Country, Spain) at the Innovative Polymer Group of Prof. David Mecerreyes. The quality of the multidisciplinary research program will broaden the scientific knowledge of the fellow and help him to set the basis for the development of a new class of products providing performance competitive with traditional electrolytes and improved safety standards.
Medically Assisted Reproduction: The Effects on Children, Adults and Families (MARTE)

Framework: Horizon 2020 — Excellent Science
Programme: European Research Council (ERC)
Theme: European research council
Destination: Starting grants
Action type: ERC actions
Panel: The Social World and Its Diversity
Panel description: Sociology, social psychology, social anthropology, education sciences, communication studies
Countries involved: United Kingdom,United Kingdom
Call: ERC Starting Grant (ERC-2018-STG, 2018)
Start date: 2019-02-01
End date: 2024-01-31
Duration (months): 60.0
Total project cost (EUR): 1398553.0
EU funding (EUR): 1398553.0
Participants: 2
Project status: SIGNED

Medically Assisted Reproduction (MAR) is one of the most important achievements of medical science in the last generation. In advanced societies, the number of MAR treatments increases every year, and, over the last four decades, more than five million MAR conceived children were born, and many more families received treatment. Given this trend, it is a public health prerogative to find out whether MAR affects the well-being of families. Prior findings are mixed and often hampered by low statistical power or conceptual limitations. I propose a programme of research that goes beyond the state-of-the-art by being the first to analyze comprehensively the effects of MAR on children, adults, and families through a combination of uniquely rich data, previously unused research designs, and conceptual innovations. First, in contrast to past work using small or convenience samples, I use extremely detailed and large datasets from population registers and surveys. Second, I compare the impact of MAR on different domains of life by analysing its effects on a range of adult and child outcomes (e.g., physical/mental health, education, union stability), thereby allowing me to investigate trade-offs that have not been previously tested. Third, I use innovative research designs to test whether the impact of MAR is causal by comparing children conceived through MAR treatments to their spontaneously conceived siblings, and adults who successfully conceive through MAR to those who are unsuccessful. The project has the potential to produce ground-breaking results that will impact future research in this field. Moreover, the project will have important policy implications, as its findings will be immediately relevant to health professionals advising couples seeking MAR treatments, to public health authorities allocating resources to mitigate the potentially negative effects of MAR on health, and to policy-makers considering whether to (further) subsidize MAR treatments.
Baltic Biomaterials Centre of Excellence (BBCE)

Framework: Horizon 2020 — Spreading excellence and widening participation
Programme: Widening participation and spreading excellence
Theme: Improved access to Excellence
Action type: Coordination and support actions
Countries involved: Germany,Switzerland,Latvia
Call: Teaming Phase 2 (H2020-WIDESPREAD-2018-01, 2018)
Start date: 2020-01-01
End date: 2026-12-31
Duration (months): 84.0
Total project cost (EUR): 14999869.5
EU funding (EUR): 14999869.5
Participants: 6
Project status: SIGNED

The Baltic Biomaterials Centre of Excellence (BBCE) overall objective is to develop a joint BBCE for advanced biomaterials development based on the long-term strategic cooperation between Riga Technical University, Latvian Institute of Organic Synthesis , Rīga Stradiņš University and LLC Rīga Stradiņš University Institute of Stomatology, on the one part, and AO Research Institute Davos, Switzerland and Friedrich-Alexander University of Erlangen-Nuremberg, Germany, on the other part. The activities of the BBCE will provide an opportunity to combine existing expertise and infrastructure to create critical mass and excellence in the development of biomaterials for bone regeneration and solutions for creative biomedical applications. The expected impact of the BBCE project through Teaming Phase 2 in long term will be achieved through fruitful cooperation between the BBCE core partners in Latvia and industry (including SMEs) bringing the high performance products into the market, increasing scientific excellence, elevating the impact factor of peer-reviewed publications and Hirsch index in the field of biomaterials. Collecting "critical mass" of high level scientists and/or technology developers will be achieved ensuring career development to provide highly-qualified staff at BBCE core partners able to work in a multinational and interdisciplinary environment and capable to cope with their future career demands in an efficient and innovative way.

Keywords: biomaterials,medical devices,centre of excellence
Intelligent investment analysis of early-stage companies (INTEL-1)

Framework: Horizon 2020 — Industrial Leadership
Programme: Information and Communication Technologies
Action type: SME instrument
Countries involved: United Kingdom
Call: Open Disruptive Innovation Scheme (implemented through the SME instrument) (H2020-SMEINST-1-2015, 2015)
Start date: 2016-03-01
End date: 2016-08-31
Duration (months): 6.0
Total project cost (EUR): 71429.0
EU funding (EUR): 50000.0
Participants: 1
Project status: CLOSED

The European startup ecosystem is booming. It has attracted more than $3.5bn of venture funding in Q3 2015, the highest in 5 years. A major factor fueling this growth is a higher-resolution venture finance industry, which has opened up the traditional Venture Capital (VC) space to new types of early-stage investors: angels, crowdfunding networks, accelerators and micro-VCs. The challenge these early-stage investors face is the lack of commercially available business intelligence tools to support the decision-making process. The high-risk nature of early-stage investing increases the odds of mis-allocating capital and is raising concerns from industry professionals and regulators alike. Crowd Analytics is a first-of-its-kind large-scale data analytics and visualisation platform that helps investors assess the risk profile and investment-readiness of early-stage companies. The system collects structured and unstructured data from a number of public and private sources, correlates them using proprietary algorithmic analysis, deduces relevant insights and presents them to the user in an intuitive and structured manner. This results in reliable, data-driven insights across the complete spectrum of early-stage investment opportunities that will be offered through a subscription service.

Keywords: due diligence